NCT06971133

Brief Summary

The aim of the present study is to investigate causes of secondary and prolonged fever during treatment of viral encephalitis and bacterial meningitis in children aged from one month to 18 years .

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started May 2025

Shorter than P25 for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 29, 2025

Completed
2 days until next milestone

Study Start

First participant enrolled

May 1, 2025

Completed
13 days until next milestone

First Posted

Study publicly available on registry

May 14, 2025

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2026

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2026

Completed
Last Updated

May 14, 2025

Status Verified

May 1, 2025

Enrollment Period

11 months

First QC Date

April 29, 2025

Last Update Submit

May 10, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Causes of secondary and prolonged fever during treatment of bacterial meningitis and viral encephalitis

    Causes of secondary and prolonged fever during treatment of bacterial meningitis and viral encephalitis

    Basline

Eligibility Criteria

Age1 Month - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Included children aged from one month to 18 years , who were diagnosed as bacterial meningitis or viral encephalitis and admitted to neurological department at AUCH and develop secondary or prolonged fever despite appropriate treatment .

You may qualify if:

  • Children from one month to 18 years.
  • Who were diagnosed with bacterial meningitis or viral encephalitis and admitted to neurological department at Assiut University Children's Hospital (AUCH).
  • Develop secondary or prolonged fever despite appropriate treatment.

You may not qualify if:

  • Pediatric patients with suspected autoimmune encephalitis.
  • Patient on immunosuppressive therapy (e.g., post-organ transplant, chemotherapy).
  • Pediatric patients suspected metabolic disorders.
  • Those with suspected endocrine dysfunction.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Brouwer MC, McIntyre P, de Gans J, Prasad K, van de Beek D. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev. 2010 Sep 8;(9):CD004405. doi: 10.1002/14651858.CD004405.pub3.

    PMID: 20824838BACKGROUND

Study Officials

  • Prof. Mostafa Shafeek Khalaf Tawfeek, Professor of Pediatrics

    Assiut University

    PRINCIPAL INVESTIGATOR
  • Dr. Khalaf Abd El-Aal Sayed Mohamed, Lecturer of Pediatrics

    Assiut University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Kerolos Atef Shafeek Tanious

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctor

Study Record Dates

First Submitted

April 29, 2025

First Posted

May 14, 2025

Study Start

May 1, 2025

Primary Completion

April 1, 2026

Study Completion

May 1, 2026

Last Updated

May 14, 2025

Record last verified: 2025-05